Guizhou Xinbang Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Guizhou Xinbang Pharmaceutical Co., Ltd. was established in January 1995, with its registered address in Luodian County, Guizhou Province and its management headquarters located in Guiyang City. In April 2010, the company was listed on the Shenzhen Stock Exchange with stock code 002390. At present, the company has a registered capital of 1.944 billion yuan, total assets of 9.629 billion yuan, 43 holding enterprises, and nearly 6000 employees. It has developed into a full industry chain enterprise group that integrates medical services, pharmaceutical circulation, and pharmaceutical industry. Medical service sector: The company has 7 medical institutions, including Guizhou Medical University Affiliated Oncology Hospital, Affiliated Baiyun Hospital, Affiliated Wudang Hospital, Guiyi Anshun Hospital, Renhuai New Chaoyang Hospital, Liuzhi Boda Hospital, and Liupanshui Anju Hospital, each located in Guiyang, Zunyi, Anshun, and Liupanshui, with over 5000 beds. Among them, Cancer Hospital is the only tertiary cancer specialized hospital in Guizhou Province, with qualifications as a clinical trial institution for cancer specialized drugs and a tumor research laboratory; Baiyun Hospital and Wudang Hospital are influential tertiary comprehensive hospitals; Each medical institution has its own unique disciplines and has established a high-quality hospital network with obvious competitive advantages, which has formed a certain brand effect in Guizhou Province. Under the strategic plan of building a high-tech medical group, the company always adheres to the "patient-centered" medical philosophy and adheres to standardized, scientific, and refined management ideas. Through the guidance of core tumor hospitals and Baiyun Hospital, the company will take the construction of Baiyun Clinical Teaching Center of Guizhou Medical University as an opportunity to fully strengthen the integrated development of medical education and research, and provide a talent team for the group's medical service institutions The output of discipline construction and management team to achieve the company's goal of medical service scale. Continuously improving the level of diagnosis and treatment and the quality of medical services to meet the growing diversified health needs of the people. Pharmaceutical distribution sector: The company has more than 20 distribution companies under its umbrella, including Kekai Pharmaceutical, Zhuoda Pharmaceutical, Xinbang Pharmaceutical, Kekai Pharmacy, Xindali Biotechnology, and Zhongkang Ze'ai Medical Equipment Co., Ltd. Its main business is the sales and distribution services of drugs and medical devices, with tens of thousands of varieties, basically covering the procurement needs of Class III hospitals, and has formed a focus on Guiyang, covering key areas such as Qiannan, Zunyi, Bijie, and Tongren, The distribution network radiating throughout the province has accumulated rich channel resources, and has obvious advantages in customer resources, distribution network, agent varieties, and service capabilities. The company will further improve its delivery service level, optimize delivery efficiency, ensure delivery quality, meet market demand through diversified and comprehensive pharmaceutical circulation and supporting services, and continue to expand business coverage to achieve scale and intensive operation. Pharmaceutical industry sector: the company's business covers the fields of Chinese herbal medicine planting, research and development and production of Chinese herbal medicine pieces and other big health products, Chinese medicine health care, production and sales of traditional Chinese patent medicines and simple preparations, forming a closed industrial chain. In terms of traditional Chinese patent medicines and simple preparations, it has five GMP production lines, 41 national drug approved brands, 3 national high quality and high price varieties, 2 traditional Chinese medicine protected varieties, and 6 exclusive varieties. Its flagship products, such as Maixuekang Capsule and Yixinshu Capsule, have won the title of "Guizhou Famous Brand Product" for many times. Guizhou Tongde Pharmaceutical Co., Ltd., jointly invested and constructed by the company and Jiangsu Provincial Demonstration Hospital of Traditional Chinese Medicine, is one of the first batch of strategic cooperation key projects in traditional Chinese medicine between Jiangsu and Guizhou provinces, committed to building a national demonstration base for authentic Chinese medicine decoction pieces. Adhering to the corporate philosophy of "Sincerity and Sincerity, Unity and Prosperity, Healthy People, and Development of People's Livelihood", and practicing the core values of "Honest Cooperation, Realistic Innovation, and Pursuit of Results", the company adheres to honest operation and innovative development, and is listed as a "National Key Leading Enterprise in Agricultural Industrialization", "National Poverty Alleviation Leading Enterprise", and "Top 100 Enterprises in National Ethnic Trade and Ethnic Special Commodity Production", The "Eighth Batch of National Ethnic Unity and Progress Demonstration Units" have been awarded honors such as the "China Red Cross Society Contribution Medal", "China Red Cross Humanitarian Service Award", "China Industrial Industry Fulfillment of Social Responsibility Five Star Enterprise", "Qiannan Prefecture Poverty Alleviation Outstanding Contribution Private Enterprise", "Capital Market Service Guizhou Poverty Alleviation Contribution Award", and have been continuously listed on the reputation list of Chinese listed companies, We have been awarded titles such as "Most Growing Listed Company", "Best Business Model Listed Company", and "2021 Guizhou Province Excellent Enterprise Honorary Title", and have been continuously listed on the "Double Top 100" list in Guizhou Province. In 2022, we ranked 5th in the "Guizhou Top 100 Private Enterprises" and 3rd in the "Guizhou Manufacturing Top 20 Private Enterprises", continuously leading the pharmaceutical industry in Guizhou Province. |
| Headquarter | Qiannan Buyei and Miao Autonomous Prefecture |
| Establish Date | 1/27/1995 |
| Listed Code | 002390.SZ |
| Listed Date | 4/16/2010 |
| Chairman | Anji. |
| CEO | Kong Lingzhong. |
| Website | www.xinbang.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
